Desloratadine is an advanced, long-acting second-generation tricyclic antihistamine that exhibits an exceptionally high affinity for the human H1 receptor. It acts as a selective inverse agonist that keeps peripheral histamine pathways continuously suppressed for a full 24-hour cycle. Beyond blocking H1 receptors, its molecular matrix displays distinct anti-inflammatory properties, such as inhibiting the release of pro-inflammatory cytokines and chemokines from mast cells and basophils, providing comprehensive protection against nasal congestion and systemically driving down allergy-induced inflammation without causing sedation.